6 terminated. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 6 |
| Phase 1 | 1 | Terminated 1 |
Follow Parathyroid Diseases: new trials by email Literature Review of Parathyroid Diseases trials Research Report on Parathyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients Denosumab Inj 60 mg/ml, Placebo - Osteoporosis, Renal Osteodystrophy | Phase 2 | Terminated | Thomas Nickolas, MD MS | 8 | 2020-01-16 | 2024-07-25 |
| Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism Cinacalcet hydrochloride, Standard of Care - Chronic Kidney Disease, Hyperparathyroidism, Secondary | Phase 2 | Terminated | Amgen | 18 | 2012-06-22 | 2020-06-17 |
| Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism Etelcalcetide - Secondary Hyperparathyroidism | Phase 2 | Terminated | KAI Pharmaceuticals | 30 | 2012-03-01 | 2017-04-13 |
| Teriparatide for Postsurgical Hypoparathyroidism Teriparatide - Hypoparathyroidism Post-surgical | Phase 2 | Terminated | Mayo Clinic | 5 | 2010-11-01 | 2014-12-22 |
| Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome Metyrosine, Placebo - Velo-cardio-facial Syndrome, Psychosis | Phase 2 | Terminated | Bausch Health Americas, Inc. | 2 | 2010-06-01 | 2019-11-22 |
| Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients Cinacalcet HCl - Secondary Hyperparathyroidism, Hypercalcemia | Phase 1 / Phase 2 | Terminated | Montefiore Medical Center | 4 | 2007-02-09 | 2025-04-29 |
Hyperparathyroidism, Secondary (3) · Chronic Kidney Disease-Mineral and Bone Disorder (2) · DiGeorge Syndrome (1) · Hypercalcemia (1) · Hypoparathyroidism (1) · Osteoporosis (1) · Psychotic Disorders (1) · Renal Insufficiency, Chronic (1)
Endocrine System Diseases (6) · Hyperparathyroidism (4) · Calcium Metabolism Disorders (3) · Chronic Disease (3) · Disease Attributes (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Metabolic Diseases (3) · Musculoskeletal Diseases (3) · Nutritional and Metabolic Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3)
Cinacalcet (2) · Denosumab (1) · Standard of Care (1) · Teriparatide (1) · alpha-Methyltyrosine (1) · etelcalcetide hydrochloride (1)
Amgen (1) · Bausch Health Americas, Inc. (1) · KAI Pharmaceuticals (1) · Mayo Clinic (1) · Montefiore Medical Center (1) · Thomas Nickolas, MD MS (1)
United States (5) · Belgium (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Mexico (1) · Netherlands (1) · New Zealand (1) · Poland (1) · Russia (1) · Slovakia (1)
M D (1) · Maria Coco, MD, MS (1) · Marius Stan, MD (1) · Robert J Shprintzen, PhD (1) · Thomas Nickolas, MD, MS (1)